je.st
news
Tag: therapies
Yumanity Therapeutics Launched By Tony Coles, M.D. To Identify And Develop New Therapies For Neurodegenerative Diseases Caused By Protein Misfolding
2014-12-29 02:11:13| drugdiscoveryonline Home Page
Renowned biotech industry leader Tony Coles, M.D. recently announced the launch of Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfolding
Tags: develop
caused
identify
tony
President Obama Highlights New DARPA Program Aimed At Developing Novel Therapies Customized To Individual Patients
2014-08-28 11:06:39| rfglobalnet Home Page
The body’s peripheral nervous system constantly monitors the status of internal organs and helps regulate biological responses to infection, injury or other imbalances. When this regulatory process goes awry due to injury or illness, peripheral nerve signals can actually exacerbate a condition, causing pain, inflammation or immune dysfunction.
Tags: to
program
individual
president
Advaxis, Merck to test immune therapies against prostate cancer
2014-08-25 12:19:09| Biotech - Topix.net
Advaxis Inc on Monday said it will test an experimental immuno-oncology drug in combination with a high-profile immunotherapy from Merck & Co Inc as a treatment for patients with advanced prostate cancer.
Tags: test
cancer
immune
therapies
UPDATE 1-Bristol, Merck, Roche immune therapies are cancer meeting focus
2014-05-15 03:35:01| Biotech - Topix.net
When the world's leading cancer doctors meet in Chicago next month, new treatments from Merck & Co, Bristol-Myers Squibb Co and Roche Holding AG that help the immune system fight disease are expected to capture much of the spotlight.
Tags: update
focus
meeting
cancer
Exclusive: Biogen prices hemophilia drug on par with older therapies
2014-04-18 21:08:28| Biotech - Topix.net
Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.